Content Item Descriptions Row 4 The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation. Row 5 Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time Row 6 Unique identification of a single radiopharmaceutical administration event. Row 8 The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site. Row 9 The time the radiopharmaceutical was administered to the patient for imaging purposes. Row 11 Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID XXX3 Pre-Administration Measured Activity Row 13, TID XXX3 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9. Does not include estimated extravasation activity. Row 25 Identifies the person administering the product. Row 26 The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging. TID Radiopharmaceutical Organ Data The Radiopharmaceutical Organ Data conveys the organ information of a single radiopharmaceutical administration event. Radiopharmaceutical ORGAN DATA Type: Extensible Order: Significant NL Rel with VT Concept VM Req Condition Value Set Parent Name Type Constraint 1 EV (CDXX06, 1 M $99SUP159, Organ Dose”) 2 > CODE EV (T-D0060, 1 M DCID () SRT, Radiosensitive “Body Organ”) Organs 3 >> HAS NUM EV (G-D701, 1 U = EV (g, UCUM, SRT, “Mass”) “grams”) 4 HAS TEXT EV (G-C036, 1 M SRT, “Measurement Method”)
Content Item Descriptions Row 4 The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation. Row 5 Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time Row 6 Unique identification of a single radiopharmaceutical administration event. Row 8 The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site. Row 9 The time the radiopharmaceutical was administered to the patient for imaging purposes. Row 11 Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID XXX3 Pre-Administration Measured Activity Row 13, TID XXX3 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9. Does not include estimated extravasation activity. Row 25 Identifies the person administering the product. Row 26 The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging. TID Radiopharmaceutical Organ Data The Radiopharmaceutical Organ Data conveys the organ information of a single radiopharmaceutical administration event. Radiopharmaceutical ORGAN DATA Type: Extensible Order: Significant NL Rel with Parent VT Concept Name VM Req Type Condition Value Set Constraint 1 EV (CDXX06, $99SUP159, Organ Dose”) 1 M 2 > CODE EV (T-D0060, SRT, “Body Organ”) 1 M DCID () Radiosensitive Organs 3 >> HAS NUM EV (G-D701, SRT, “Mass”) 1 U = EV (g, UCUM, “grams”) 4 HAS TEXT EV (G-C036, SRT, “Measurement Method”) 1 M